CRM Publications

Guest RV, Boulter L, Kendall TJ, Minnis-Lyons SE, Walker R, Wigmore SJ, Sansom OJ, Forbes SJ.  2014.  Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma.Cancer Res. 74(4):1005-10.

Roberts GA, Houston PJ, White JH, Chen K, Stephanou AS, Cooper LP, Dryden DTF, Lindsay JA.  2013.  Impact of target site distribution for Type I restriction enzymes on the evolution of methicillin-resistant Staphylococcus aureus (MRSA) populations.Nucleic Acids Res. 41(15):7472-84.

Roberts GA, Chen K, Cooper LP, White JH, Blakely GW, Dryden DTF.  2012.  Removal of a frameshift between the hsdM and hsdS genes of the EcoKI Type IA DNA restriction and modification system produces a new type of system and links the different families of Type I systems.Nucleic Acids Res. 40(21):10916-24.

Hills D, Gribi R, Ure J, Buza-Vidas N, Luc S, Jacobsen SEirik W, Medvinsky AL.  2011.  Hoxb4-YFP reporter mouse model: a novel tool for tracking HSC development and studying the role of Hoxb4 in hematopoiesis.Blood. 117(13):3521-8.

Serfiotis-Mitsa D, Herbert AP, Roberts GA, Soares DC, White JH, Blakely GW, Uhrín D, Dryden DTF.  2010.  The structure of the KlcA and ArdB proteins reveals a novel fold and antirestriction activity against Type I DNA restriction systems in vivo but not in vitro.Nucleic Acids Res. 38(5):1723-37.

McMahon SA, Roberts GA, Johnson KA, Cooper LP, Liu H, White JH, Carter LG, Sanghvi B, Oke M, Walkinshaw MD et al..  2009.  Extensive DNA mimicry by the ArdA anti-restriction protein and its role in the spread of antibiotic resistance.Nucleic Acids Res. 37(15):4887-97.

Harkiolaki M, Holmes SL, Svendsen P, Gregersen JW, Jensen LT, McMahon R, Friese MA, van Boxel G, Etzensperger R, Tzartos JS et al..  2009.  T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides.Immunity. 30(3):348-57.

Serfiotis-Mitsa D, Roberts GA, Cooper LP, White JH, Nutley M, Cooper A, Blakely GW, Dryden DTF.  2008.  The Orf18 gene product from conjugative transposon Tn916 is an ArdA antirestriction protein that inhibits type I DNA restriction-modification systems.J Mol Biol. 383(5):970-81.